Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Neurimmune
-
-
AstraZenecaPharma Science & Research
First RSV vaccine trial for infants offers significant results
by adminby adminSummary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the first investigational long-acting antibody, designed to protect…
-
AstraZenecaCompaniesGlobal MarketPharma Science & Research
AstraZeneca in the News: EMA Greenlights RSV Vaccine, Leif Johansson Departing
by adminby adminSummary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…
-
AstraZenecaGlobal Market
AstraZeneca, Neurimmune Sign Exclusive Collaboration and License Agreement for NI006
by adminby adminSynopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…